Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response.

Nature - 2 Sept 2004

Reed Michael B, Domenech Pilar, Manca Claudia, Su Hua, Barczak Amy K, Kreiswirth Barry N, Kaplan Gilla, Barry Clifton E

Abstract excerpt

Fifty million new infections with Mycobacterium tuberculosis occur annually, claiming 2-3 million lives from tuberculosis worldwide. Despite the apparent lack of significant genetic heterogeneity between strains of M. tuberculosis, there is mounting evidence that considerable heterogeneity exists in molecules important in disease pathogenesis. These differences may manifest in the ability of some isolates to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bone Marrow Cells
Share to Glycolipids

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immunity, Innate

Share to Inflammation Mediators

Share to Macrophages

Share to Multienzyme Complexes

Share to Mycobacterium tuberculosis

Share to Tuberculosis

Source

Identifiers

PMID: 15343336
DOI: 10.1038/nature02837

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response.PMID 15343336Read ↗

The Phenolic Glycolipid of Mycobacterium tuberculosis Differentially Modulates the Early Host Cytokine Response but Does Not in Itself Confer HypervirulenceSemantic proximity Read ↗

Virulence of selected Mycobacterium tuberculosis clinical isolates in the rabbit model of meningitis is dependent on phenolic glycolipid produced by the bacilli.Semantic proximity Read ↗

Mycobacterium tuberculosis Strains Are Differentially Recognized by TLRs with an Impact on the Immune ResponseSemantic proximity Read ↗

The W-Beijing Lineage of <i>Mycobacterium tuberculosis</i> Overproduces Triglycerides and Has the DosR Dormancy Regulon Constitutively UpregulatedSemantic proximity Read ↗

Playing hide-and-seek with host macrophages through the use of mycobacterial cell envelope phthiocerol dimycocerosates and phenolic glycolipidsSemantic proximity Read ↗

Trisaccharides of Phenolic Glycolipids Confer Advantages to Pathogenic Mycobacteria through Manipulation of Host-Cell Pattern-Recognition ReceptorsSemantic proximity Read ↗

Mycobacterium tuberculosis inhibits human innate immune responses via the production of TLR2 antagonist glycolipidsSemantic proximity Read ↗

Underestimated Manipulative Roles of Mycobacterium tuberculosis Cell Envelope Glycolipids During InfectionSemantic proximity Read ↗

Host and bacterial lipid metabolism during tuberculosis infections: possibilities to synergise host- and bacteria-directed therapiesSemantic proximity Read ↗

Lipids of Pathogenic Mycobacteria: Contributions to Virulence and Host Immune SuppressionSemantic proximity Read ↗

Recent advances in deciphering the contribution of Mycobacterium tuberculosis lipids to pathogenesisSemantic proximity Read ↗

Biosynthesis of mycobacterial lipids by polyketide synthases and beyondSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.